Shares of other companies:
May 1, 2024 Inflation Persistence: No Fed Rate Cuts in Sight
April 29, 2024 Tesla, Baidu Join Forces for Self-Driving Tech in China
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
Nvidia’s Stock Is Still A Bargain
May 2, 2024
Amazon Q1 Earnings: Strong Value Proposition
May 1, 2024
3M Stock: Dividend Likely Cut In Half
May 1, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
KURA Stock News and Mentions of Kura Oncology, Inc. Stocktwits
Updated: May 2, 2024 (11:06)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Kura Oncology Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Kura Oncology, Inc. (KURA).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Kura Oncology stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Kura Oncology, Inc. (KURA)
May 2, 2024 (12:55) / "Stocknews.com" (by StockNews.com Staff)
ALPN: Biotech Buyers Beware: 3 Stocks to Avoid
Biotechnology is at the forefront of a paradigm shift in healthcare, combining cutting-edge technology with biological processes to create transformative solutions.
In Article Trend: Neutral
April 25, 2024 (11:30) / "GlobeNewswire" (by Inc.)
Kura Oncology to Report First Quarter 2024 Financial Results
SAN DIEGO, April 25, 2024 ( GLOBE NEWSWIRE ) -- Kura Oncology, Inc. ( Nasdaq: KURA ) , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2024 financial results after ...
In Article Trend: Neutral
April 25, 2024 (11:30) / "Benzinga" (by Globe Newswire)
Kura Oncology to Report First Quarter 2024 Financial Results - Kura Oncology ( NASDAQ:KURA )
SAN DIEGO, April 25, 2024 ( GLOBE NEWSWIRE ) -- Kura Oncology, Inc. KURA, a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will report first quarter 2024 financial results after the close of ...
In Article Trend: Neutral
April 22, 2024 (11:30) / "GlobeNewswire" (by Inc.)
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
- Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for ...
In Article Trend: Somewhat-Bullish
April 16, 2024 (08:16) / "Stocknews.com" (by Defense World Staff)
Kura Oncology ( NASDAQ:KURA ) Downgraded by StockNews.com to Sell
StockNews.com cut shares of Kura Oncology ( NASDAQ:KURA - Free Report ) from a hold rating to a sell rating in a research note released on Monday. A number of other analysts have also recently weighed in on the stock. Mizuho assumed coverage on shares of Kura Oncology in a report on Friday, ...
In Article Trend: Somewhat-Bullish
April 10, 2024 (11:30) / "GlobeNewswire" (by Kura Oncology)
Kura Oncology to Participate in Stifel Targeted Oncology Forum
SAN DIEGO, April 10, 2024 ( GLOBE NEWSWIRE ) -- Kura Oncology, Inc. ( NASDAQ: KURA ) , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in Stifel 2024 Targeted Oncology Forum.
In Article Trend: Somewhat-Bullish
April 5, 2024 (11:30) / "GlobeNewswire" (by Kura Oncology)
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
SAN DIEGO, April 05, 2024 ( GLOBE NEWSWIRE ) -- Kura Oncology, Inc. ( the "Company" ) ( Nasdaq: KURA ) , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on April 1, 2024, the Compensation ...
In Article Trend: Somewhat-Bullish
April 4, 2024 (08:24) / "Stocknews.com" (by Defense World Staff)
Kura Oncology ( NASDAQ:KURA ) Upgraded to "Hold" at StockNews.com
StockNews.com upgraded shares of Kura Oncology ( NASDAQ:KURA - Free Report ) from a sell rating to a hold rating in a report released on Wednesday morning. A number of other research analysts also recently commented on the stock.
In Article Trend: Somewhat-Bullish
March 6, 2024 (12:30) / "GlobeNewswire" (by Kura Oncology)
Kura Oncology Reports First Patient Dosed in Trial of KO-2806 Plus Cabozantinib in Renal Cell Carcinoma
- Company anticipates dosing of KO-2806 in combination with adagrasib in KRASG12C-mutant NSCLC next quarter ...
In Article Trend: Neutral
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website